$IMLFF News Article - InMed Pharmaceuticals Announces Transition to a Single Cannabinoid Investigational Drug Candidate - INM-755 - for its Epidermolysis Bullosa Program https://marketwirenews.com/news-releases/inme...31556.html
My Twitter: WhyteStocks